FI941259A0 - Nya alfa-mannosidasinhibitorer - Google Patents

Nya alfa-mannosidasinhibitorer

Info

Publication number
FI941259A0
FI941259A0 FI941259A FI941259A FI941259A0 FI 941259 A0 FI941259 A0 FI 941259A0 FI 941259 A FI941259 A FI 941259A FI 941259 A FI941259 A FI 941259A FI 941259 A0 FI941259 A0 FI 941259A0
Authority
FI
Finland
Prior art keywords
alpha
beta
new alpha
mannosidase inhibitors
mannosidase
Prior art date
Application number
FI941259A
Other languages
English (en)
Finnish (fi)
Other versions
FI941259A (sv
FI105270B (sv
Inventor
Robert A Farr
Mohinder S Kang
Norton P Peet
Sai P Sunkara
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI941259A publication Critical patent/FI941259A/sv
Publication of FI941259A0 publication Critical patent/FI941259A0/sv
Application granted granted Critical
Publication of FI105270B publication Critical patent/FI105270B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Indole Compounds (AREA)
FI941259A 1991-09-18 1994-03-17 Förfarande för framställning av terapeutiskt användbara oktahydro-1H-1-pyrindin-4,5,6,7-tetroler FI105270B (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US76157991A 1991-09-18 1991-09-18
US76157991 1991-09-18
US89317192 1992-06-03
US07/893,171 US5262425A (en) 1991-09-18 1992-06-03 α-mannosidase inhibitors
PCT/US1992/006707 WO1993005781A1 (en) 1991-09-18 1992-08-10 Novel alpha-mannosidase inhibitors
US9206707 1992-08-10

Publications (3)

Publication Number Publication Date
FI941259A FI941259A (sv) 1994-03-17
FI941259A0 true FI941259A0 (sv) 1994-03-17
FI105270B FI105270B (sv) 2000-07-14

Family

ID=27117010

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941259A FI105270B (sv) 1991-09-18 1994-03-17 Förfarande för framställning av terapeutiskt användbara oktahydro-1H-1-pyrindin-4,5,6,7-tetroler

Country Status (15)

Country Link
US (1) US5262425A (sv)
EP (1) EP0641327B1 (sv)
JP (1) JP3226173B2 (sv)
KR (1) KR100244012B1 (sv)
AT (1) ATE175960T1 (sv)
AU (1) AU659486B2 (sv)
CA (1) CA2116224C (sv)
DE (1) DE69228259T2 (sv)
DK (1) DK0641327T3 (sv)
ES (1) ES2127758T3 (sv)
FI (1) FI105270B (sv)
GR (1) GR3029745T3 (sv)
HU (1) HU216789B (sv)
NO (1) NO300372B1 (sv)
WO (1) WO1993005781A1 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
EP0934318A1 (en) * 1996-10-01 1999-08-11 Glycodesign Inc. Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
US6395745B1 (en) 1997-04-15 2002-05-28 Glycodesign, Inc. Alkaloid halide salts of swainsonine and methods of use
US6245316B1 (en) 1997-10-08 2001-06-12 David Platt Enhancement of delivery of radioimaging and radioprotective agents
EP1023290A1 (en) * 1997-10-24 2000-08-02 Glycodesign Inc. Synthesis of swainsonine salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4031102A (en) * 1972-10-21 1977-06-21 John Wyeth & Brother Limited Cyclopenteno[b]pyridine derivatives
GB2088860B (en) * 1980-12-09 1984-05-23 Wyeth John & Brother Ltd Process for preparing ring-fused pyridine derivatives

Also Published As

Publication number Publication date
HU216789B (hu) 1999-08-30
JP3226173B2 (ja) 2001-11-05
EP0641327B1 (en) 1999-01-20
CA2116224C (en) 2003-06-03
US5262425A (en) 1993-11-16
FI941259A (sv) 1994-03-17
GR3029745T3 (en) 1999-06-30
WO1993005781A1 (en) 1993-04-01
ES2127758T3 (es) 1999-05-01
JPH06510785A (ja) 1994-12-01
AU2477192A (en) 1993-04-27
HU9400787D0 (en) 1994-06-28
HUT70527A (en) 1995-10-30
FI105270B (sv) 2000-07-14
ATE175960T1 (de) 1999-02-15
AU659486B2 (en) 1995-05-18
DE69228259T2 (de) 1999-06-02
EP0641327A4 (en) 1994-06-01
NO300372B1 (no) 1997-05-20
NO940972D0 (no) 1994-03-17
NO940972L (no) 1994-03-17
CA2116224A1 (en) 1993-04-01
KR100244012B1 (ko) 2000-03-02
DK0641327T3 (da) 1999-09-13
DE69228259D1 (de) 1999-03-04
EP0641327A1 (en) 1995-03-08

Similar Documents

Publication Publication Date Title
NO944430D0 (no) 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer
DK0563345T3 (da) Nye 4-arylpiperaziner og 4-arylpiperidiner
CO4290353A1 (es) Agonistas de estrogeno
ES2148229T3 (es) Eteres y tioeteres en la posicion 17 de 4-aza-esteroides.
DK0516349T3 (da) 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister
DK0386997T3 (da) Anvendelse af 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamin-derivater i behandlingen af psykose, inflammation og som immunosuppressive midler
ES2195970T3 (es) L-ribavirina y usos de la misma.
DK0471756T3 (da) Saccharinderivater, der er egnede som proteolytiske enzyminhibitorer, og fremstilling deraf
NO932547L (no) Isoksazolederivater for behandling av irritabelt tarmsyndrom
FI941259A0 (sv) Nya alfa-mannosidasinhibitorer
PT91468A (pt) Processo para a preparacao de um novo antibiotico mersacidina e de composicoes farmaceuticas que o contem
ES2034678T3 (es) Procedimiento para aumentar la productividad de los cerdos.
PA7801701A1 (es) Compuestos ariltios
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
PT94011A (pt) Processo para a preparacao de 8 alfa- acilamino-ergolinas e de composicoes farmaceuticas que as contem
PT100001A (pt) Novos derivados glicosilicos inibidores da gluco-hidrolase uteis como agentes antidiabeticos
MX9305453A (es) Metodo para tratar infecciones virales.
IT8820949A0 (it) Procedimento per la preparazione di derivati della (trans) 4 fenil lprolina.
FI922016A0 (fi) Foerfarande foer framstaellning av dubbelskyddade 1-karba(1-detia)-3-kefem-4-karboxylsyror.
IT8921855A0 (it) Dispositivo per eseguire l'asportazione chirurgica di segmenti di organi, per esempio segmenti epatici.
ITRM940151A0 (it) Impiego di esteruretani per la riconcia.
IT9020228A0 (it) Apparato per trattamenti igienicizzanti di foraggi o simili
IT222255Z2 (it) Vestito sterile per intensificatore di brillanza
ITBO910224U1 (it) Morsa per il bloccaggio rapido di organi meccanici
ITMI931684A0 (it) Procedimento per la preparazione di derivati del 5,4- diidrocarbostirile